Abstract:Mycoplasmas, the smallest self-replicating prokaryotes without a cell wall, are the most prevalent and extensively studied species in humans. They significantly contribute to chronic respiratory tract illnesses and pneumonia, with children and adolescents being particularly vulnerable. Mycoplasma pneumoniae (M. pneumoniae) infections typically tend to be self-limiting and mild but can progress to severe or even life-threatening conditions in certain individuals. Extrapulmonary effects often occur without pneumonia, and both intrapulmonary and extrapulmonary complications operate through separate pathological mechanisms. The indirect immune-mediated damage of the immune system, vascular blockages brought on by vasculitis or thrombosis and direct harm from invasion or locally induced inflammatory cytokines are potential causes of extrapulmonary manifestations due to M. pneumoniae. Proteins associated with adhesion serve as the primary factor crucial for the pathogenicity of M. pneumoniae, relying on a specialized polarized terminal attachment organelle. The type and density of these host receptors significantly impact the adhesion and movement of M. pneumoniae, subsequently influencing the pathogenic mechanism and infection outcomes. Adjacent proteins are crucial for the proper assembly of the attachment organelle, with variations in the genetic domains of P1, P40 and P90 surfaces contributing to the variability of clinical symptoms and offering new avenues for developing vaccines against M. pneumoniae infections. M. pneumoniae causes oxidative stress within respiratory tract epithelial cells by adhering to host cells and releasing hydrogen peroxide and superoxide radicals. This oxidative stress enhances the vulnerability of host cells to harm induced by oxygen molecules. The lack of superoxide dismutase and catalase of bacteria allows it to hinder the catalase activity of the host cell, leading to the reduced breakdown of peroxides. Lung macrophages play a significant role in managing M. pneumoniae infection, identifying it via Toll-like receptor 2 and initiating the myeloid differentiation primary response gene 88-nuclear factor κΒ signaling cascade. However, the precise mechanisms enabling M. pneumoniae to evade intracellular host defenses remain unknown, necessitating further exploration of the pathways involved in intracellular survival. The present comprehensive review delves into the pathogenesis of M. pneumoniae infection within the pulmonary system and into extrapulmonary areas, outlining its impact.

A comprehensive review of Mycoplasma pneumoniae infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis

The Clinical And Molecular Epidemiology Of Mycoplasma Pneumoniae Infections

Mycoplasma Pneumoniae and Bronchial Asthma

Progress in the Diagnosis and Treatment of Childhood Mycoplasma Pneumoniae Infections

Research Progress of Pulmonary Microecology and Its Relationship with Common Pulmonary Diseases

The change of asthma-associated immunological parameters in children with mycoplasma pneumoniae infection

Insight into the Pathogenic Mechanism of Mycoplasma pneumoniae

Mycoplasma Pneumoniae from the Respiratory Tract and Beyond

New progress in etiological diagnosis and treatment of mycoplasma pneumoniae infection

Therapeutic progress of Mycoplasma pneumoniae pneumonia in children

Mycoplasma Pneumoniae‐associated Necrotizing Pneumonitis in Children

Exploring the pathogenetic mechanisms of Mycoplasmapneumoniae (Review)

Progress in Immune Research of Mycoplasma Pneumoniae Infection

Immune response plays a role in Mycoplasma pneumoniae pneumonia

Integrative study of pulmonary microbiome, transcriptome and clinical outcomes in Mycoplasma pneumoniae pneumonia

Airway microbiota in children with bronchial mucus plugs caused by Mycoplasma pneumoniae pneumonia

Mycoplasma Pneumoniae Infection and Infantile Asthma

Thrombosis associated with mycoplasma pneumoniae infection (Review)

Reemergence of Mycoplasma pneumoniae disease: Pathogenesis and new approaches

Critical insights from recent outbreaks of Mycoplasma pneumoniae: decoding the challenges and effective interventions strategies

Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development